Intellectual Property
Every innovation that improves lives, advances society, and drives our economy starts with an idea. Strong intellectual property rights—including patents, trademarks, and copyrights—protect and incentivize those ideas. When inventors, researchers, engineers, artists, and entrepreneurs have legal certainty that their work will be protected and rewarded, they can keep the transformative ideas coming. Intellectual property protections also shield consumers from dangerous fake and counterfeit goods, giving people assurances that products—from life-saving medicines to toys—are safe and authentic.
Featured
2025 International IP Index
The 13th edition of the U.S. Chamber’s International IP Index is a comprehensive assessment of the world’s intellectual property frameworks. The Index illustrates how smart policies foster innovation and creativity, stimulate economic growth, and unlock opportunity.
Learn More
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber’s Global Innovation Policy Center champions innovation and creativity through intellectual property standards so businesses can save lives, solve problems, create jobs, advance growth, and enhance society. Our work to protect strong intellectual property rights begins in Washington, D.C., and extends to countries across the globe.
Events
- Intellectual Property19th Annual USPTO IP Attaché RoundtableTuesday, December 0908:30 AM EST - 11:00 AM ESTJW Marriott Washington DC, 1331 Pennsylvania Avenue NW, Washington, DC 20004Learn More
- Security and ResilienceDisaster Resilience Forum: Beyond the PayoffWednesday, December 1008:30 AM EST - 10:30 AM ESTCharleston Marriott, Charleston, South CarolinaLearn More
- Security and ResilienceInflation, global growth challenges and the middle marketWednesday, December 1001:00 PM EST - 01:45 PM ESTVirtualLearn More
Latest Content
- The Senator refuses to have a hearing on Dr. Bertagnolli's nomination unless the Administration agrees to use new, and unprecedented, government price setting authority over private sector life science innovators.The Supreme Court recently closed out the 2022-2023 term with a series of high-profile decisions that have dominated headlines.This Hill letter was sent to the Members of the Senate Committee on Appropriations, on the FY24 Commerce, Justice, Science, and Related Agencies Appropriations Legislation.This Hill letter was sent to the Members of the Senate Committee on Appropriations, on the Fiscal Year 2024 Financial Services and General Government Appropriations bill.This Hill letter was sent to the Members of the House Committee on Appropriations, on the Fiscal Year 2024 Financial Services and General Government Appropriations bill.This Hill letter was sent to the Members of the House Committee on Appropriations, on the Fiscal Year 2024 Homeland Security Appropriations bill.This Hill letter was sent to the Members of the Senate Committee on the Judiciary, opposing S. 1094, the "Journalism Competition and Preservation Act (JCPA) of 2023."This Statement for the Record was sent to the Senate HELP Committee for the hearing, "The Need to Make Insulin Affordable for All Americans."This Hill letter was sent to the Members of the Senate Committee on Health, Education, Labor and Pensions, on S. 1067, the "Ensuring Timely Access to Generics Act of 2023,” S. 1114, the “Expanding Access to Low-Cost Generics Act of 2023,” S. 1214, the “RARE Act,” and S. 1339, the “Pharmacy Benefit Manager Reform Act.”
